WHO ICTRP trial

The Effect of Evening Primrose Oil on Clinical Symptoms in Women with Polycystic…

IRCT20120718010324N73 · Iranian Registry of Clinical Trials (IRCT) · Recruiting

Key facts

Trial ID IRCT20120718010324N73
Public title The Effect of Evening Primrose Oil on Clinical Symptoms in Women with Polycystic Ovary Syndrome
Scientific title The Effect of Evening Primrose Oil on Clinical Symptoms in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial
Primary sponsor Tabriz University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Recruiting
Study type interventional
Phase 3
Countries Iran (Islamic Republic of);Iran (Islamic Republic of);Iran (Islamic Republic of);Iran (Islamic Republic of)
Conditions Polycystic Ovary Syndrome (PCOS). Polycystic ovarian syndrome;E28.2
Interventions Intervention 1: Intervention group: For each person three matte container including 30 1000 mg evening primrose oil capsules will be prepared with a certain number. At the beginning of the study, a container including evening primrose oil…
Registration date Nov 8, 2022
Target size 62
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations